The American Society of Hematology (ASH) invites you to San Diego for our 53rd annual meeting. This event offers invaluable benefits for all attendees, including:
The opportunity to grow professionally: Hematology is a constantly changing field, and ASH’s Education and Scientific Program can help you stay up-to-date on the latest research, therapies, and tools you need to succeed.
The meeting offers many networking events that will allow you to connect with colleagues and interact with leaders in the field to learn and share your ideas.
Greetings From the President
2011 has already proven to be an inspiring and rewarding year for hematology: we’re discovering new ways to conquer blood diseases in the laboratory and helping translate those breakthroughs into lifesaving treatments for patients all over the world. As one example, whole genome sequencing was used successfully for the first time to diagnose and guide the treatment of a patient with acute leukemia. In another case, a small oligonucleotide was designed to block the adhesion of sickle erythrocytes to endothelium and shown to reduce mortality in a mouse model of sickle cell disease. It is my distinct honor to invite you to learn more about 2011’s top hematology developments at the premier event in our field: the 53rd Annual Meeting and Exposition of the American Society of Hematology (ASH) at the San Diego Convention Center in San Diego, California. I am confident that, armed with knowledge of the latest research and clinical advances in our exciting discipline, attendees will travel home from this year’s meeting inspired to further advance the field in 2012.
Our Education Program, co-chaired by Monica Bessler, MD, PhD, and Ellis Neufeld, MD, PhD, promises to provide practicing hematologists with invaluable information on nearly 30 of the most important areas of clinical progress, including groundbreaking advances in genomic studies of hematologic malignancies, new management strategies for bone failure syndromes, and innovative hematopoietic stem cell transplantation methodologies for benign disorders. In addition, two Education Program sessions held jointly with the American Association of Blood Banks (AABB) will focus on transfusion medicine, another important area for the practicing hematologist.
Physician scientists should look no further than our Scientific Program to learn about the hottest areas of hematology research. Featured topics of our Scientific Program, organized by ASH’s 17 scientific committees and co-chaired by Mary Dinauer, MD, PhD, and Nancy Speck, PhD, include discussions of metabolic and DNA methylation changes in leukemia, the role of microparticles in hematologic disorders, and innovative strategies to enhance regenerative potential of hematopoietic stem cells.
Attendees will want to come early to get a seat for Sunday afternoon’s Plenary Scientific Session, the annual meeting’s main event, since we will begin by honoring David Nathan, MD, with the Society’s highest award, the Wallace H. Coulter Award for Lifetime Achievement in Hematology. I hope you will join me to celebrate Dr. Nathan’s remarkable career, spanning more than five decades, during which he has established one of the world’s most successful training programs, made important discoveries in thalassemia and other blood disorders, and aggressively promoted translational research in the field.
I also look forward to announcing this year’s Mentor Award recipients and recognizing Christoph Klein, MD, PhD, with the Dameshek Prize for his outstanding accomplishments, which have had a large impact on the understanding of human blood and the immune system, as well as Ching-Hon Pui, MD, who will receive the Henry M. Stratton Medal for his many significant contributions to childhood leukemia research.
I would also like to call your attention to this year’s special lectures. George Daley, MD, will present this year’s E. Donnall Thomas Lecture, “Hematopoietic, Embryonic, and Induced Pluripotent Stem Cells: Diseases, Myths, and Medicines,” which will explore the promises and challenges of using genetically modified human embryonic stem cells and personalized induced pluripotent stem (iPS) cells derived from patients by somatic cell reprogramming. ASH’s Ernest Beutler Lecture and Prize recipients Janet Rowley, MD, and Brian Druker, MD, will present their prestigious two-part lecture, “Chronic Myeloid Leukemia (CML): A Success Story from Chromosomes to Effective Therapy,” that will elaborate on their contributions to advances in the treatment of CML. The Ham-Wasserman Lecture, “Angiogenesis in Health and Disease,” will be presented by Peter Carmeliet, MD, PhD, and include a discussion of the molecular basis for angiogenesis, as well as emerging mechanisms of resistance against anti-angiogenic therapy and novel strategies and molecular drug targets to overcome these challenges.
A plethora of Special-Interest Sessions round out our annual meeting program. Practicing hematologists due to recertify in the next few years will want to be sure to attend the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) Learning Session. Back for a second year, this special session provides an opportunity for attendees to collaborate with workshop leaders and colleagues to answer ABIM hematology module questions and earn recertification credit.
Attendees focused on basic science research will not want to miss the Special Symposium on the Basic Science of Hemostasis and Thrombosis, presented by the Scientific Committees on Hemostasis, Thrombosis and Vascular Biology, and Platelets. This symposium will highlight the year’s seminal research advances in the fields of thrombosis, blood coagulation and fibrinolysis, and platelet biology.
I hope clinicians and researchers alike will attend our Presidential Symposium, which will focus on bone marrow failure syndromes. Joining me for this special session will be Monica Bessler, MD, PhD, Benjamin Ebert, MD, DPhil, and Alan D’Andrea, MD.
I am extremely proud of the exceptional, diverse program that my colleagues have assembled. I hope you will join me in December to experience these talks first-hand, reconnect with old friends, and enjoy the beauty of San Diego.
J. Evan Sadler, MD, PhD